Yükleniyor... / Loading...
This study looks at how pharmacogenetic information can be used to improve treatment through a patient care pathway in people with early-onset diabetes. It included patients diagnosed with diabetes before age 30 who are currently under 50 years old. It was carried out as a study with no assigned phase and has been completed.
The summary above is a plain-language rendering of the official record. The original English title is shown for reference.
Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.
Inclusion Criteria: * clinical diagnosis of diabetes * diagnosed under 30 years of ages * current age less than 50 years * willing and able to provide informed consent. Exclusion Criteria: * age over 50 years * age at diagnosis over 30 years * adult with incapacity to consent * child with incapacity to assent